The Obstructive Sleep Apnea Syndrome (OSAS) is characterised by periods of cessation and reduction of airflow during sleep with oxygen desaturation. Clinical symptoms are snoring, unquiet sleep, daytime fatigue and diminished intellectual ability. OSAS has severe health consequences including burnout, cardiovascular disease, high blood pressure and cholesterol levels, as well as an increased risk of heart attack.
Of apnea patients, 56% has positional OSAS, for whom positional therapy can be very effective. Because current means for positional therapy have low compliance however, requests for better ones are made.
NightBalance is developing an effective yet comfortable solution to this problem in the form of an intelligent device. The Sleep Position Trainer reduces previous problems related to in positional therapy. Elements involve the ability to move freely during the night, a system that enables patients to gradually get used to sleeping in new positions, avoiding sleep disruption and active patient monitoring by the physician but also by the patient self. With these elements, the innovative Sleep Position Trainer significantly increases therapy compliance and thereby improves treatment results.
Nightbalance was acquired by Philips in 2018